REPLY DOI
Ahmet Hondur,

Gulnaz Moazami,

Gözde Hondur

и другие.

Ophthalmology, Год журнала: 2024, Номер unknown

Опубликована: Ноя. 1, 2024

Endothelial Dysfunction: Redox Imbalance, NLRP3 Inflammasome, and Inflammatory Responses in Cardiovascular Diseases DOI Creative Commons
Cláudia Penna, Pasquale Pagliaro

Antioxidants, Год журнала: 2025, Номер 14(3), С. 256 - 256

Опубликована: Фев. 23, 2025

Endothelial dysfunction (ED) is characterized by an imbalance between vasodilatory and vasoconstrictive factors, leading to impaired vascular tone, thrombosis, inflammation. These processes are critical in the development of cardiovascular diseases (CVDs) such as atherosclerosis, hypertension ischemia/reperfusion injury (IRI). Reduced nitric oxide (NO) production increased oxidative stress key contributors ED. Aging further exacerbates ED through mitochondrial oxidative/nitrosative stress, heightening CVD risk. Antioxidant systems like superoxide-dismutase (SOD), glutathione-peroxidase (GPx), thioredoxin/thioredoxin-reductase (Trx/TXNRD) pathways protect against stress. However, their reduced activity promotes ED, vulnerability IRI. Metabolic syndrome, comprising insulin resistance, obesity, hypertension, often accompanied Specifically, hyperglycemia worsens endothelial damage promoting Obesity leads chronic inflammation changes perivascular adipose tissue, while associated with increase The NLRP3 inflammasome plays a significant role being triggered factors reactive oxygen nitrogen species, ischemia, high glucose, which contribute inflammation, injury, exacerbation Treatments, N-acetyl-L-cysteine, SGLT2 or inhibitors, show promise improving function. Yet complexity suggests that multi-targeted therapies addressing metabolic disturbances essential for managing CVDs syndrome.

Язык: Английский

Процитировано

2

Endothelial cytoskeleton in mechanotransduction and vascular diseases DOI

Linlu Jin,

Yixue Qin,

Yili Zhao

и другие.

Journal of Biomechanics, Год журнала: 2025, Номер 182, С. 112579 - 112579

Опубликована: Фев. 9, 2025

Язык: Английский

Процитировано

1

Unlocking New Frontiers in Cell Signaling and Communication and Fostering New Collaborative Interactions and Scientific Initiatives: Lessons Learned from the International Cellular Communication Network Society (ICCNS) Workshop DOI Creative Commons
Bernard Perbal, Ralf Weiskirchen, Brahim Chaqour

и другие.

Опубликована: Апрель 15, 2025

Язык: Английский

Процитировано

0

LIM kinases in cardiovascular health and disease DOI Creative Commons
Olubodun M. Lateef, Christopher Foote, Gavin Power

и другие.

Frontiers in Physiology, Год журнала: 2024, Номер 15

Опубликована: Дек. 18, 2024

The Lim Kinase (LIMK) family of serine/threonine kinases is comprised LIMK1 and LIMK2, which are central regulators cytoskeletal dynamics via their well-characterized roles in promoting actin polymerization destabilizing the cellular microtubular network. LIMKs have been demonstrated to modulate several fundamental physiological processes, including cell cycle progression, motility migration, differentiation. These processes play important maintaining cardiovascular health. However, LIMK activity healthy pathological states system poorly characterized. This review highlights molecular mechanisms involved activation inactivation, examining its pathophysiology vascular cardiac diseases such as hypertension, aneurysm, atrial fibrillation, valvular heart disease. It addresses LIMKs' involvement that support health, vasculogenesis, angiogenesis, endothelial mechanotransduction. also features how participates cell, smooth muscle cardiomyocyte physiology implications states. A few recent preclinical studies demonstrate therapeutic potential inhibition. We conclude by proposing future research should focus on clinical relevance inhibitors agents reduce burden disease improve patient outcomes.

Язык: Английский

Процитировано

1

REPLY DOI
Ahmet Hondur,

Gulnaz Moazami,

Gözde Hondur

и другие.

Ophthalmology, Год журнала: 2024, Номер unknown

Опубликована: Ноя. 1, 2024

Процитировано

0